- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Do | Stellantis N.V.: Stellantis and Factorial Energy Reach Key Milestone in Solid-State Battery Development | 62 | Stellantis and Factorial Energy Reach Key Milestone in Solid-State Battery Development Stellantis and Factorial Energy successfully validated automotive-sized solid-state battery cells with 375Wh/kg... ► Artikel lesen | ||
| Do | Atria Oyj: Decisions of Atria Plc's Annual General Meeting | 78 | Atria Plc Company announcement 24 April 2025 at 3.00 p.m.
Decisions of Atria Plc's Annual General Meeting
Atria Plc's Annual General Meeting was held today in Helsinki at Musiikkitalo. The General... ► Artikel lesen | ||
| Do | OEM International AB: Interim report | 42 | Q1 2025
First quarter of 2025Incoming orders increased by 4% to SEK 1,401 million (1,351)Net sales increased by 3% to SEK 1,373 million (1,331)Operating profit increased by 1% to SEK 197 million (196)EBITA... ► Artikel lesen | ||
| Do | Herantis Pharma Oyj: Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders and constitutive meeting of the Board of Directors | 40 | Herantis Pharma Plc
Company release, 24 April 2025 at 3.00 p.m. Eastern European Summer Time
Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders and constitutive meeting of the... ► Artikel lesen | ||
| Do | Biotage AB: Resolutions at the Annual General Meeting in Biotage AB (publ) on 24 April 2025 | 32 | Biotage AB (publ) (Reg. No. 556539-3138) today, on 24 April 2025, held its Annual General Meeting. The Board of Directors' complete proposals have previously been published and are available at the... ► Artikel lesen | ||
| Do | ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative R&D Trends for Inflammasome Inhibitors, and Provides Update on Inflammasome ASC Inhibitor IC 100's Development Status | 18 | WESTON, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; "ZyVersa"), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment... ► Artikel lesen | ||
| Do | ZenaTech Inc.: ZenaTech's ZenaDrone Granted FAA Part 137 Approval for Agricultural Drone Operations Addressing a $6 Billion Global Agricultural Drone Market Growing to $24 Billion by 2032 | 183 | VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones... ► Artikel lesen | ||
| Do | Plato Gold Corp.: Plato Gold Reports on 2024 Year-End Results | 37 | Toronto" April 24, 2025 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) ("Plato" or the "Company") an exploration company with a portfolio of properties... ► Artikel lesen | ||
| Do | SRM Entertainment, Inc.: SRM Entertainment Receives Six-Month Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement | 40 | Winter Park, FL, April 24, 2025 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (Nasdaq: SRM)(the "Company") announced today that it has received a notice from the Nasdaq Staff, which has determined that... ► Artikel lesen | ||
| Do | Dyne Therapeutics, Inc.: Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy | 43 | - Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned... ► Artikel lesen | ||
| Do | FTI Consulting, Inc.: FTI Consulting Reports First Quarter 2025 Financial Results | 88 | First Quarter 2025 Revenues of $898.3 Million, Down 3% Compared to $928.6 Million in Prior Year QuarterFirst Quarter 2025 EPS of $1.74 and Adjusted EPS of $2.29, Compared to EPS and Adjusted EPS of... ► Artikel lesen | ||
| Do | FirstService Corporation: FirstService Reports First Quarter Results | 65 | Operating highlights: Three monthsended March 31 2025 2024 Revenues (millions)$1,250.8 $1,158.0 Adjusted EBITDA (millions) (note 1) 103.3 83.4 Adjusted EPS (note 2) 0.92 0.67 ... ► Artikel lesen | ||
| Do | BriaCell Therapeutics Corp.: BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS | 49 | (IMAGES BELOW) Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast cancer patientTreatment well-tolerated and patient remains on study with... ► Artikel lesen | ||
| Do | AxiTrader Limited: Axi Delivers Unbeatably Tight Spreads on Key Markets Including Gold, Crypto, and Forex | 317 | SYDNEY, April 24, 2025 (GLOBE NEWSWIRE) -- Axi, a leading global online trading broker, is proud to announce its latest commitment to industry-leading pricing with some of the most competitive spreads... ► Artikel lesen | ||
| Do | Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer | 193 | AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology
Lead product AVC-S-101 is a TROP2-targeting booster being... ► Artikel lesen | ||
| Do | Qben Infra AB: Qben Infra engages Interim CEO | 46 | The Board of Directors of Qben Infra AB (publ) ('Qben Infra') has engaged Leif Chr. Salomonsen as Interim CEO with effect from today. He replaces Øivind Horpestad, who is now leaving the company. Øivind... ► Artikel lesen | ||
| Do | Bufab AB: Resolutions at the Annual General Meeting in Bufab AB | 44 | At Bufab's Annual General Meeting (AGM) which was held today on 24 April 2025, the following principal resolutions were passed.
Adoption of the income statements and balance sheets and resolutions on... ► Artikel lesen | ||
| Do | Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2025 | 36 | GREAT NECK, N.Y., April 24, 2025 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the "Company") announced today that its net income for the three months ended March 31, 2025 was... ► Artikel lesen | ||
| Do | Nasdaq, Inc.: Nasdaq and AWS Unlock New Era of Growth for Global Capital Markets with Next Generation Infrastructure Solutions | 223 | Nasdaq and AWS announce modernization blueprint to drive the benefits of cloud into local market infrastructures through flexible deployment while maintaining data sovereignty and resilience
As... ► Artikel lesen | ||
| Do | Nasdaq, Inc.: Nasdaq Reports First Quarter 2025 Results; Diversified Business Model Driving Broad-Based Revenue Growth | 103 | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2025. First quarter 2025 net revenue1 was $1.2 billion, an increase... ► Artikel lesen | ||
| Do | Nasdaq, Inc.: Nasdaq Announces 13% Increase in Quarterly Dividend to $0.27 Per Share | 45 | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.27 per share on the company's outstanding common... ► Artikel lesen | ||
| Do | First Northwest Bancorp Reports First Quarter 2025 Improved Profitability | 42 | PORT ANGELES, Wash., April 24, 2025 (GLOBE NEWSWIRE) -- First Northwest Bancorp (Nasdaq: FNWB) ("First Northwest" or the "Company") today reported net income of $1.5 million for the first quarter... ► Artikel lesen | ||
| Do | Valley National Bank: Valley National Bancorp Announces First Quarter 2025 Results | 45 | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the first quarter 2025 of $106.1 million... ► Artikel lesen | ||
| Do | CDON AB: CDON initiates review of strategic alternatives in order to realize full business potential | 40 | The Board of Directors of CDON AB ("CDON" or the "Company") initiates a review of strategic alternatives.
CDON hereby announces that its Board of Directors has decided to initiate a process to explore... ► Artikel lesen | ||
| Do | CDON AB: Interim report Q1 2025 | 49 | FIRST QUARTER FOR THE GROUP
Total gross merchandise value (GMV) decreased by 12% to SEK 350.4 (397.2) million.
Net sales decreased by 16% to SEK 80.5 (95.8) million.
Take rate increased by 1.2 percentage... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
